Chinedu Iheyinwa Ukaegbu, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms, Hereditary Nonpolyposis | 14 | 2023 | 380 | 1.860 |
Why?
|
Germ-Line Mutation | 17 | 2024 | 1858 | 1.170 |
Why?
|
DNA Mismatch Repair | 10 | 2023 | 428 | 0.980 |
Why?
|
DNA Glycosylases | 3 | 2020 | 125 | 0.720 |
Why?
|
Genes, APC | 1 | 2020 | 145 | 0.680 |
Why?
|
Jews | 1 | 2020 | 356 | 0.620 |
Why?
|
Intestinal Polyposis | 3 | 2020 | 42 | 0.460 |
Why?
|
Neoplastic Syndromes, Hereditary | 3 | 2023 | 245 | 0.370 |
Why?
|
Genetic Testing | 8 | 2024 | 3537 | 0.370 |
Why?
|
Colorectal Neoplasms | 6 | 2024 | 6938 | 0.370 |
Why?
|
Microsatellite Instability | 4 | 2023 | 716 | 0.370 |
Why?
|
Adenoma | 1 | 2020 | 2163 | 0.330 |
Why?
|
Pancreatic Neoplasms | 5 | 2024 | 5368 | 0.280 |
Why?
|
MutS Homolog 2 Protein | 7 | 2023 | 197 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 9 | 2024 | 17904 | 0.240 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2024 | 1728 | 0.200 |
Why?
|
Endometrial Neoplasms | 2 | 2021 | 1366 | 0.190 |
Why?
|
Genetic Counseling | 2 | 2024 | 627 | 0.180 |
Why?
|
Community Health Centers | 1 | 2024 | 461 | 0.180 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2020 | 97 | 0.180 |
Why?
|
Prenylation | 1 | 2019 | 37 | 0.170 |
Why?
|
Smad4 Protein | 1 | 2020 | 191 | 0.170 |
Why?
|
Models, Genetic | 3 | 2021 | 3442 | 0.170 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 314 | 0.160 |
Why?
|
Colonoscopy | 2 | 2024 | 1394 | 0.160 |
Why?
|
Stomach Diseases | 1 | 2020 | 134 | 0.160 |
Why?
|
Early Detection of Cancer | 2 | 2024 | 3201 | 0.160 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 250 | 0.150 |
Why?
|
Models, Statistical | 2 | 2022 | 5079 | 0.140 |
Why?
|
BRCA2 Protein | 1 | 2021 | 805 | 0.140 |
Why?
|
Watchful Waiting | 1 | 2020 | 491 | 0.130 |
Why?
|
Urologic Neoplasms | 1 | 2019 | 314 | 0.130 |
Why?
|
Intestine, Small | 1 | 2021 | 1206 | 0.120 |
Why?
|
Colectomy | 1 | 2020 | 688 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 641 | 0.120 |
Why?
|
Risk Assessment | 8 | 2024 | 23996 | 0.120 |
Why?
|
BRCA1 Protein | 1 | 2021 | 1158 | 0.120 |
Why?
|
Gene Frequency | 1 | 2020 | 3606 | 0.110 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4878 | 0.100 |
Why?
|
Radiotherapy | 2 | 2020 | 1498 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1745 | 0.090 |
Why?
|
Heterozygote | 3 | 2022 | 2787 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2022 | 2539 | 0.090 |
Why?
|
Family | 2 | 2024 | 3195 | 0.080 |
Why?
|
Telemedicine | 2 | 2024 | 3052 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1459 | 0.080 |
Why?
|
Middle Aged | 17 | 2024 | 220921 | 0.080 |
Why?
|
Pedigree | 3 | 2021 | 4542 | 0.080 |
Why?
|
Age Factors | 6 | 2021 | 18399 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9647 | 0.070 |
Why?
|
Carcinoma | 1 | 2019 | 2330 | 0.070 |
Why?
|
Germ Cells | 2 | 2021 | 634 | 0.070 |
Why?
|
Cohort Studies | 5 | 2021 | 41495 | 0.070 |
Why?
|
Calibration | 1 | 2019 | 818 | 0.070 |
Why?
|
Female | 20 | 2024 | 392705 | 0.070 |
Why?
|
Male | 19 | 2024 | 360846 | 0.070 |
Why?
|
Medical History Taking | 2 | 2020 | 774 | 0.070 |
Why?
|
Humans | 28 | 2024 | 761596 | 0.070 |
Why?
|
Neoplasms | 3 | 2022 | 22173 | 0.060 |
Why?
|
Phenotype | 2 | 2021 | 16592 | 0.060 |
Why?
|
Adenomatous Polyposis Coli Protein | 2 | 2017 | 181 | 0.060 |
Why?
|
Sex Factors | 4 | 2021 | 10554 | 0.060 |
Why?
|
Aged | 12 | 2024 | 169310 | 0.060 |
Why?
|
Occult Blood | 1 | 2024 | 198 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5821 | 0.050 |
Why?
|
Mutation | 4 | 2022 | 30053 | 0.050 |
Why?
|
Adult | 12 | 2024 | 221210 | 0.050 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.050 |
Why?
|
Heredity | 1 | 2021 | 148 | 0.040 |
Why?
|
DNA-Binding Proteins | 4 | 2021 | 9610 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58984 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 196 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11122 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 59260 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15266 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2020 | 604 | 0.030 |
Why?
|
Genes, p16 | 1 | 2017 | 160 | 0.030 |
Why?
|
Risk Factors | 5 | 2021 | 74213 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13642 | 0.030 |
Why?
|
Penetrance | 1 | 2017 | 383 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21019 | 0.030 |
Why?
|
Sample Size | 1 | 2017 | 841 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2017 | 601 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 346 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2017 | 764 | 0.030 |
Why?
|
Patient Participation | 1 | 2021 | 1445 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2469 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2017 | 5799 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 2015 | 836 | 0.020 |
Why?
|
Adolescent | 4 | 2021 | 88326 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21355 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20100 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3578 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3639 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26129 | 0.020 |
Why?
|
Anxiety | 1 | 2024 | 4573 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3032 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3358 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4111 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6345 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3008 | 0.020 |
Why?
|
Pregnancy | 1 | 2019 | 29890 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13446 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2805 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2917 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2898 | 0.010 |
Why?
|
Depression | 1 | 2024 | 8126 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10451 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13255 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29629 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2022 | 9032 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 80647 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12990 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39106 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42232 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54423 | 0.010 |
Why?
|
Child | 1 | 2020 | 80158 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36193 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168475 | 0.000 |
Why?
|